From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
- Report
- May 2024
United Kingdom
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
- Report
- May 2024
North America
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
- Report
- May 2024
Middle East
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
- Report
- May 2024
Asia Pacific
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
- Report
- May 2024
United States
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
- Report
- May 2024
United Kingdom
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
From €2013EUR$2,095USD£1,731GBP
€3834EUR$3,990USD£3,297GBP
Prostaglandins are a class of hormones that play a role in endocrine and metabolic disorders. They are involved in a variety of physiological processes, including inflammation, blood pressure regulation, and cell growth. Prostaglandins are used to treat a range of endocrine and metabolic disorders, including diabetes, obesity, and thyroid disorders. They are also used to treat conditions such as asthma, arthritis, and ulcers. Prostaglandins are available in both oral and injectable forms, and can be used in combination with other drugs to treat more complex conditions.
The prostaglandin market is a rapidly growing sector of the pharmaceutical industry. Companies are investing heavily in research and development to develop new and improved prostaglandin-based treatments. Some of the major players in the prostaglandin market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Other companies such as Sanofi, AstraZeneca, and Bayer are also active in the prostaglandin market. Show Less Read more